tetano
Editor, Senior Moderator
Lancet Infect Dis. 2015 Feb 5. pii: S1473-3099(14)70999-5. doi: 10.1016/S1473-3099(14)70999-5. [Epub ahead of print]
[h=1]The development of global vaccine stockpiles.[/h] Yen C[SUP]1[/SUP], Hyde TB[SUP]2[/SUP], Costa AJ[SUP]3[/SUP], Fernandez K[SUP]3[/SUP], Tam JS[SUP]4[/SUP], Hugonnet S[SUP]3[/SUP], Huvos AM[SUP]3[/SUP], Duclos P[SUP]4[/SUP], Dietz VJ[SUP]2[/SUP], Burkholder BT[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Global vaccine stockpiles, in which vaccines are reserved for use when needed for emergencies or supply shortages, have effectively provided countries with the capacity for rapid response to emergency situations, such as outbreaks of yellow fever and meningococcal meningitis. The high cost and insufficient supply of many vaccines, including oral cholera vaccine and pandemic influenza vaccine, have prompted discussion on expansion of the use of vaccine stockpiles to address a wider range of emerging and re-emerging diseases. However, the decision to establish and maintain a vaccine stockpile is complex and must take account of disease and vaccine characteristics, stockpile management, funding, and ethical concerns, such as equity. Past experience with global vaccine stockpiles provide valuable information about the processes for their establishment and maintenance. In this Review we explored existing literature and stockpile data to discuss the lessons learned and to inform the development of future vaccine stockpiles.
Copyright ? 2015 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.
PMID: 25661473 [PubMed - as supplied by publisher]
[h=1]The development of global vaccine stockpiles.[/h] Yen C[SUP]1[/SUP], Hyde TB[SUP]2[/SUP], Costa AJ[SUP]3[/SUP], Fernandez K[SUP]3[/SUP], Tam JS[SUP]4[/SUP], Hugonnet S[SUP]3[/SUP], Huvos AM[SUP]3[/SUP], Duclos P[SUP]4[/SUP], Dietz VJ[SUP]2[/SUP], Burkholder BT[SUP]5[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Global vaccine stockpiles, in which vaccines are reserved for use when needed for emergencies or supply shortages, have effectively provided countries with the capacity for rapid response to emergency situations, such as outbreaks of yellow fever and meningococcal meningitis. The high cost and insufficient supply of many vaccines, including oral cholera vaccine and pandemic influenza vaccine, have prompted discussion on expansion of the use of vaccine stockpiles to address a wider range of emerging and re-emerging diseases. However, the decision to establish and maintain a vaccine stockpile is complex and must take account of disease and vaccine characteristics, stockpile management, funding, and ethical concerns, such as equity. Past experience with global vaccine stockpiles provide valuable information about the processes for their establishment and maintenance. In this Review we explored existing literature and stockpile data to discuss the lessons learned and to inform the development of future vaccine stockpiles.
Copyright ? 2015 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.
PMID: 25661473 [PubMed - as supplied by publisher]